The role of multiparametric MRI in biopsy-naive prostate cancer

Authors

Amir H. Lebastchi, National Cancer Institute (NCI)
Peter A. Pinto, National Cancer Institute (NCI)

Document Type

Journal Article

Publication Date

5-1-2019

Journal

Nature Reviews Urology

Volume

16

Issue

5

DOI

10.1038/s41585-019-0173-7

Abstract

© 2019, US Government. Results of recent trials have shown the superiority of mpMRI to TRUS-guided systematic biopsy for detecting clinically significant prostate cancer. However, only performing an mpMRI risks missing MRI-invisible lesions and, therefore, there might be added value in performing both targeted and systematic biopsies in biopsy-naive patients.

APA Citation

Lebastchi, A., & Pinto, P. (2019). The role of multiparametric MRI in biopsy-naive prostate cancer. Nature Reviews Urology, 16 (5). http://dx.doi.org/10.1038/s41585-019-0173-7